In 2018, Van de Ven et al. showed that cells resistant to irradiation and tumors derived from a PTEN/Trp53-deficient mouse model of advanced PCa exhibited increased sensitivity to radiation after being treated with NanoOlaparib, a lipid-based injectable nanoformulation of Olaparib. Here, PTEN is linked to posterior cortical atrophy.